NANO-X IMAGING LTD announced a new collaboration to advance the Nanox.ARC 3D imaging system and Nanox artificial intelligence solutions in Korea with AhealthZ and SCL Science, AhealthZ’s affiliated company and subsidiary of global healthcare group SCL. Under the collaboration, AhealthZ plans to assist Nanox in efforts to secure local authorizations and licenses to enable the importation, marketing and sales of the Nanox.ARC in South Korea. The Nanox.ARC is a digital tomosynthesis system that uses multiple sources of X-rays to produce a three-dimensional, tomographic images. Compared to similar X-ray tomosynthesis based devices, Nanox.ARC has a smaller footprint, utilizes a cold cathode system, and has the potential to be a cost-effective and scalable imaging solution in healthcare settings. The collaboration will also include SCL Science integrating Nanox’s AI solutions in remote image analysis and other operations. Nanox’s AI solutions include its HealthCCSng cardiac solution, HealthOST bone solution and HealthFLD fatty liver solution, and are designed to help identify patients with asymptomatic undetected chronic disease and initiate earlier diagnosis and preventative management. Additionally, Nanox.MARKETPLACE, a teleradiology services platform that provides remote access to radiology and cardiology experts, will potentially be integrated with SCL Science’s teleradiology centers in South Korea and other overseas markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market
- Nano-X Imaging price target lowered to $14 from $22.40 at Ladenburg
- Largest borrow rate increases among liquid names
- Nano-X Imaging Advances with U.S. Expansion and AI Diagnostics
- Nano-X Imaging reports Q4 EPS (18c), consensus (30c)